These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 1333596)
1. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine. Vuorinen P; Laustiola KE Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596 [TBL] [Abstract][Full Text] [Related]
2. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334 [TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent and -independent effects of exogenous ATP, adenosine, GTP and guanosine on vascular tone and cyclic nucleotide accumulation of rat mesenteric artery. Vuorinen P; Pörsti I; Metsä-Ketelä T; Manninen V; Vapaatalo H; Laustiola KE Br J Pharmacol; 1992 Feb; 105(2):279-84. PubMed ID: 1313722 [TBL] [Abstract][Full Text] [Related]
4. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets. Lückhoff A; Bohnert M; Busse R Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746 [TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of thrombin-induced platelet aggregation by the novel nitric oxide-donor GEA 3175 and adenosine. Grenegård M; Gustafsson MC; Andersson RG; Bengtsson T Br J Pharmacol; 1996 Aug; 118(8):2140-4. PubMed ID: 8864553 [TBL] [Abstract][Full Text] [Related]
6. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761 [TBL] [Abstract][Full Text] [Related]
7. Combined inhibitory effects of ethanol and adenosine on the responses of rabbit platelets to thrombin. Rand ML; DaCosta SM; Chahil A; Kinlough-Rathbone RL Alcohol Clin Exp Res; 1995 Oct; 19(5):1279-85. PubMed ID: 8561302 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction. Krishnamurthi S; Patel Y; Kakkar VV Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512 [TBL] [Abstract][Full Text] [Related]
9. Phorbol ester treatment inhibits thrombin but not stable GTP analogue-induced platelet granule secretion despite inhibition of phosphatidate formation with both agonists. Krishnamurthi S; Kakkar VV Biochem Biophys Res Commun; 1988 Nov; 156(3):1257-64. PubMed ID: 3056410 [TBL] [Abstract][Full Text] [Related]
10. Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Authi KS; Rao GH; Evenden BJ; Crawford N Biochem J; 1988 Nov; 255(3):885-93. PubMed ID: 3063257 [TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam. Romstedt K; Huzoor-Akbar Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062 [TBL] [Abstract][Full Text] [Related]
12. Exogenous GTP enhances the effects of sodium nitrite on cyclic GMP accumulation, vascular smooth muscle relaxation and platelet aggregation. Laustiola KE; Vuorinen P; Pörsti I; Metsä-Ketelä T; Manninen V; Vapaatalo H Pharmacol Toxicol; 1991 Jan; 68(1):60-3. PubMed ID: 1848931 [TBL] [Abstract][Full Text] [Related]
13. Effects of guanine nucleotides on the properties of 5-hydroxytryptamine secretion from electropermeabilised human platelets. Knight DE; Scrutton MC Eur J Biochem; 1986 Oct; 160(1):183-90. PubMed ID: 3021450 [TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62). Liao CH; Tzeng CC; Teng CM Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. Liao CH; Ko FN; Wu CL; Teng CM J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426 [TBL] [Abstract][Full Text] [Related]
17. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation. Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639 [TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. Faint RW; Mackie IJ; Machin SJ Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034 [TBL] [Abstract][Full Text] [Related]
19. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Salvemini D; Radziszewski W; Korbut R; Vane J Br J Pharmacol; 1990 Dec; 101(4):991-5. PubMed ID: 1707709 [TBL] [Abstract][Full Text] [Related]
20. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets. Asplund Persson A; Zalavary S; Lindström E; Whiss PA; Bengtsson T; Grenegård M Eur J Pharmacol; 2005 Jul; 517(3):149-57. PubMed ID: 15963495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]